[The inferior vena caval filter to prevent from an onset or a recurrence of acute pulmonary thromboembolism].

Patients suffered from APTE(acute pulmonary thromboembolism) are mainly treated with anticoagulation therapy. IVCF(the inferior vena cava filter) is a device to prevent the occurrence and recurrence of APTE. The use of IVCF as a treatment of thromboembolic disease applies fundamentally for patients of the less efficacy and contraindications to anticoagulation. IVCF is effective for short-term protection of APTE than anticoagulation therapy alone. Mortality from filter placement appears to be quite low, regardless of which filter is used. The majority of clinically important complications appear to involve venous thrombosis at the insertion site and the inferior vena cava obstruction in long-term, therefore the short-term temporary IVCF is useful and it requires further follow-up data.